Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Wolff%2C+Andreas+W%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Wolff%2C+Andreas+W%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Wolff%2C+Andreas+W%22&type=Person&sort=year
PubPharm (11)
1
SAFE-ROCK : A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
enthalten in:
CNS drugs
| 2024
von
Wolff, A.
|
Peine, J.
|
Höfler, J.
| +3
Wird geladen...
2
SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants
enthalten in:
CNS drugs
| 2024
von
Wolff, A.
|
Peine, J.
|
Höfler, J.
| +3
Wird geladen...
3
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD)
enthalten in:
Frontiers in aging neuroscience
| 2024
von
Wolff, A.
|
Bidner, H.
|
Remane, Y.
| +6
Wird geladen...
4
Best practice approaches to outpatient management of people living with Parkinson's disease during the COVID-19 pandemic
enthalten in:
Journal of neural transmission (Vienna, Austria : 1996)
| 2022
von
Demleitner, A.
|
Wolff, A.
|
Erber, J.
| +6
Wird geladen...
5
SARS-CoV-2 and neurodegenerative diseases : what we know and what we don't
enthalten in:
Journal of neural transmission (Vienna, Austria : 1996)
| 2022
von
Lingor, P.
|
Demleitner, A.
|
Wolff, A.
| +1
Wird geladen...
6
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
enthalten in:
Journal of neural transmission / General section
| 2022
von
Lingor, P.
|
Demleitner, A.
|
Wolff, A.
| +1
Wird geladen...
7
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
enthalten in:
Journal of neural transmission
| 2022
von
Lingor, P.
|
Demleitner, A.
|
Wolff, A.
| +1
Wird geladen...
8
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
enthalten in:
Journal of neural transmission
| 2022
von
Lingor, P.
|
Demleitner, A.
|
Wolff, A.
| +1
Wird geladen...
9
Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic
enthalten in:
Journal of neural transmission / General section
| 2022
von
Demleitner, A.
|
Wolff, A.
|
Erber, J.
| +6
Wird geladen...
10
Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic
enthalten in:
Journal of neural transmission
| 2022
von
Demleitner, A.
|
Wolff, A.
|
Erber, J.
| +6
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
11
Aufsätze
9
E-Artikel
9
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
4
Journal of neural transmission
2
CNS drugs
2
Journal of neural transmission (Vienna, Austria...
2
Journal of neural transmission / General section
1
Frontiers in aging neuroscience
Alle anzeigen ...
weniger ...
Thema
9
Parkinson’s disease
8
COVID-19
4
Alzheimer’s disease
4
Best practice
4
Journal Article
4
Management
4
Neurodegeneration
4
Neurological symptoms
4
Outpatients
4
SARS-CoV-2
2
Research Support, Non-U.S. Gov't
1
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
84477-87-2
1
COVID-19 Vaccines
1
Clinical Trial, Phase I
1
EC 2.7.11.1
1
Fasudil
1
Protein Kinase Inhibitors
1
Q0CH43PGXS
1
ROCK inhibition
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2024
8
2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
11
Englisch
Haven't found what you're looking for?
Wird geladen...